{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:22:51Z","timestamp":1778674971313,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:00:00Z","timestamp":1358380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12016-013-8357-z","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T06:44:47Z","timestamp":1358318687000},"page":"248-255","source":"Crossref","is-referenced-by-count":12,"title":["Immunoglobulin-Mediated Neuro-Cognitive Impairment: New Data and a Comprehensive Review"],"prefix":"10.1007","volume":"45","author":[{"given":"Assaf","family":"Menachem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Deri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva","family":"Katzav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"8357_CR1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","volume":"135","author":"CG Bien","year":"2012","unstructured":"Bien CG, Vincent A, Barnett MH et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622\u20131638","journal-title":"Brain"},{"key":"8357_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","volume":"223","author":"K Kaida","year":"2010","unstructured":"Kaida K, Kusunoki S (2010) Antibodies to gangliosides and ganglioside complexes in Guillain-Barre syndrome and Fisher syndrome: mini-review. J Neuroimmunol 223:5\u201312","journal-title":"J Neuroimmunol"},{"key":"8357_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","volume":"36","author":"G Zandman-Goddard","year":"2007","unstructured":"Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 36:297\u2013315","journal-title":"Semin Arthritis Rheum"},{"key":"8357_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","volume":"96","author":"M Peeters","year":"2001","unstructured":"Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96:730\u2013734","journal-title":"Am J Gastroenterol"},{"key":"8357_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0897.2005.00287.x","volume":"54","author":"JL Luborsky","year":"2005","unstructured":"Luborsky JL, Barua A, Shatavi SV, Kebede T, Abramowicz J, Rotmensch J (2005) Anti-tumor antibodies in ovarian cancer. Am J Reprod Immunol 54:55\u201362","journal-title":"Am J Reprod Immunol"},{"key":"8357_CR6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/pmic.200200679","volume":"4","author":"L Zhong","year":"2004","unstructured":"Zhong L, Peng X, Hidalgo GE, Doherty DE, Stromberg AJ, Hirschowitz EA (2004) Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer. Proteomics 4:1216\u20131225","journal-title":"Proteomics"},{"key":"8357_CR7","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood.V98.12.3421","volume":"98","author":"AJ Melendez","year":"2001","unstructured":"Melendez AJ, Bruetschy L, Floto RA, Harnett MM, Allen JM (2001) Functional coupling of FcgammaRI to nicotinamide adenine dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. Blood 98:3421\u20133428","journal-title":"Blood"},{"key":"8357_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(00)00412-4","volume":"112","author":"M Stangel","year":"2001","unstructured":"Stangel M, Compston A (2001) Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors. J Neuroimmunol 112:63\u201371","journal-title":"J Neuroimmunol"},{"key":"8357_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jlb.63.5.521","volume":"63","author":"G Sanchez-Mejorada","year":"1998","unstructured":"Sanchez-Mejorada G, Rosales C (1998) Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 63:521\u2013533","journal-title":"J Leukoc Biol"},{"key":"8357_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.iy.09.040191.002325","volume":"9","author":"JV Ravetch","year":"1991","unstructured":"Ravetch JV, Kinet JP (1991) Fc receptors. Annu Rev Immunol 9:457\u2013492","journal-title":"Annu Rev Immunol"},{"key":"8357_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-5699(93)90166-I","volume":"14","author":"JG Winkel van de","year":"1993","unstructured":"van de Winkel JG, Capel PJ (1993) Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14:215\u2013221","journal-title":"Immunol Today"},{"key":"8357_CR12","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1128\/MCB.01072-06","volume":"27","author":"K Nakamura","year":"2007","unstructured":"Nakamura K, Hirai H, Torashima T et al (2007) CD3 and immunoglobulin G Fc receptor regulate cerebellar functions. Mol Cell Biol 27:5128\u20135134","journal-title":"Mol Cell Biol"},{"key":"8357_CR13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neuroscience.2010.01.004","volume":"166","author":"S Suemitsu","year":"2010","unstructured":"Suemitsu S, Watanabe M, Yokobayashi E et al (2010) Fcgamma receptors contribute to pyramidal cell death in the mouse hippocampus following local kainic acid injection. Neuroscience 166:819\u2013831","journal-title":"Neuroscience"},{"key":"8357_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000117043","volume":"34","author":"IJ Namer","year":"1994","unstructured":"Namer IJ, Steibel J, Poulet P, Mauss Y, Mohr M, Chambron J (1994) The role of Mycobacterium tuberculosis in experimental allergic encephalomyelitis. Eur Neurol 34:224\u2013227","journal-title":"Eur Neurol"},{"key":"8357_CR15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0404.1988.tb03680.x","volume":"78","author":"AF Walls","year":"1988","unstructured":"Walls AF, Suckling AJ, Rumsby MG (1988) Autoantibody responses in the cerebrospinal fluid of guinea pigs with chronic relapsing experimental allergic encephalomyelitis. Acta Neurol Scand 78:422\u2013428","journal-title":"Acta Neurol Scand"},{"key":"8357_CR16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","volume":"11","author":"C Kamm","year":"2012","unstructured":"Kamm C, Zettl UK (2012) Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev 11:196\u2013202","journal-title":"Autoimmun Rev"},{"key":"8357_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.autrev.2003.09.006","volume":"3","author":"A Chavarria","year":"2004","unstructured":"Chavarria A, Alcocer-Varela J (2004) Is damage in central nervous system due to inflammation? Autoimmun Rev 3:251\u2013260","journal-title":"Autoimmun Rev"},{"key":"8357_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(99)01479-1","volume":"832","author":"AG Rabchevsky","year":"1999","unstructured":"Rabchevsky AG, Degos JD, Dreyfus PA (1999) Peripheral injections of Freund\u2019s adjuvant in mice provoke leakage of serum proteins through the blood\u2013brain barrier without inducing reactive gliosis. Brain Res 832:84\u201396","journal-title":"Brain Res"},{"key":"8357_CR19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","volume":"11","author":"S Shrot","year":"2002","unstructured":"Shrot S, Katzav A, Korczyn AD et al (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11:736\u2013743","journal-title":"Lupus"},{"key":"8357_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-108-3-387","volume":"108","author":"GP Holmes","year":"1988","unstructured":"Holmes GP, Kaplan JE, Gantz NM et al (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108:387\u2013389","journal-title":"Ann Intern Med"},{"key":"8357_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","volume":"8","author":"L Lorusso","year":"2009","unstructured":"Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G (2009) Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 8:287\u2013291","journal-title":"Autoimmun Rev"},{"key":"8357_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcla.20217","volume":"22","author":"Y Hokama","year":"2008","unstructured":"Hokama Y, Empey-Campora C, Hara C et al (2008) Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J Clin Lab Anal 22:99\u2013105","journal-title":"J Clin Lab Anal"},{"key":"8357_CR23","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI118990","volume":"98","author":"K Konstantinov","year":"1996","unstructured":"Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM (1996) Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 98:1888\u20131896","journal-title":"J Clin Invest"},{"key":"8357_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.mehy.2005.02.031","volume":"65","author":"R Wheatland","year":"2005","unstructured":"Wheatland R (2005) Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic\u2013pituitary\u2013adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Med Hypotheses 65:287\u2013295","journal-title":"Med Hypotheses"},{"key":"8357_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1740-2557-2-5","volume":"2","author":"SD Vernon","year":"2005","unstructured":"Vernon SD, Reeves WC (2005) Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis 2:5","journal-title":"J Autoimmune Dis"},{"key":"8357_CR26","first-page":"21","volume":"1","author":"R Klein","year":"1995","unstructured":"Klein R, Berg PA (1995) High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res 1:21\u201326","journal-title":"Eur J Med Res"},{"key":"8357_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s001060050275","volume":"46","author":"U Heller","year":"1998","unstructured":"Heller U, Becker EW, Zenner HP, Berg PA (1998) Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO 46:583\u2013586","journal-title":"HNO"},{"key":"8357_CR28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/1352458511417835","volume":"17","author":"A Feinstein","year":"2011","unstructured":"Feinstein A (2011) Multiple sclerosis and depression. Mult Scler 17:1276\u20131281","journal-title":"Mult Scler"},{"key":"8357_CR29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0074-7742(07)79015-3","volume":"79","author":"FA Luque","year":"2007","unstructured":"Luque FA, Jaffe SL (2007) Cerebrospinal fluid analysis in multiple sclerosis. Int Rev Neurobiol 79:341\u2013356","journal-title":"Int Rev Neurobiol"},{"key":"8357_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","volume":"203\u2013204","author":"J Chapman","year":"2002","unstructured":"Chapman J, Abu-Katash M, Inzelberg R et al (2002) Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci 203\u2013204:81\u201384","journal-title":"J Neurol Sci"},{"key":"8357_CR31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9343(81)90756-7","volume":"70","author":"HG Bluestein","year":"1981","unstructured":"Bluestein HG, Williams GW, Steinberg AD (1981) Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 70:240\u2013246","journal-title":"Am J Med"},{"key":"8357_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2008-1052494","volume":"17","author":"YL Danon","year":"1986","unstructured":"Danon YL, Garty BZ (1986) Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. Neuropediatrics 17:23\u201327","journal-title":"Neuropediatrics"},{"key":"8357_CR33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12016-009-8154-x","volume":"38","author":"A Katzav","year":"2010","unstructured":"Katzav A, Shoenfeld Y, Chapman J (2010) The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol 38:196\u2013200","journal-title":"Clin Rev Allergy Immunol"},{"key":"8357_CR34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12016-007-0007-x","volume":"32","author":"B Liberato","year":"2007","unstructured":"Liberato B, Levy RA (2007) Antiphospholipid syndrome and cognition. Clin Rev Allergy Immunol 32:188\u2013191","journal-title":"Clin Rev Allergy Immunol"},{"key":"8357_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","volume":"10","author":"A Katzav","year":"2001","unstructured":"Katzav A, Pick CG, Korczyn AD et al (2001) Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 10:496\u2013499","journal-title":"Lupus"},{"key":"8357_CR36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","volume":"12","author":"R Omdal","year":"2005","unstructured":"Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI (2005) Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 12:392\u2013398","journal-title":"Eur J Neurol"},{"key":"8357_CR37","doi-asserted-by":"crossref","unstructured":"Peery HE, Day GS, Dunn S, et al (2012) Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 11:863\u2013872","DOI":"10.1016\/j.autrev.2012.03.001"},{"key":"8357_CR38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.mehy.2004.08.024","volume":"64","author":"MR D\u2019Andrea","year":"2005","unstructured":"D\u2019Andrea MR (2005) Add Alzheimer\u2019s disease to the list of autoimmune diseases. Med Hypotheses 64:458\u2013463","journal-title":"Med Hypotheses"},{"key":"8357_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.autrev.2011.09.005","volume":"11","author":"F Sardi","year":"2011","unstructured":"Sardi F, Fassina L, Venturini L et al (2011) Alzheimer\u2019s disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev 11:149\u2013153","journal-title":"Autoimmun Rev"},{"key":"8357_CR40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/153331750502000303","volume":"20","author":"MR D\u2019Andrea","year":"2005","unstructured":"D\u2019Andrea MR (2005) Evidence that immunoglobulin-positive neurons in Alzheimer\u2019s disease are dying via the classical antibody-dependent complement pathway. Am J Alzheimers Dis Other Demen 20:144\u2013150","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"8357_CR41","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","volume":"13","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, McLarnon JG (2009) A leaky blood\u2013brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer\u2019s disease brain. J Cell Mol Med 13:2911\u20132925","journal-title":"J Cell Mol Med"},{"key":"8357_CR42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.autrev.2010.07.008","volume":"9","author":"T Colasanti","year":"2010","unstructured":"Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E (2010) Autoantibodies in patients with Alzheimer\u2019s disease: pathogenetic role and potential use as biomarkers of disease progression. Autoimmun Rev 9:807\u2013811","journal-title":"Autoimmun Rev"},{"key":"8357_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0306-4522(91)90121-4","volume":"40","author":"J Chapman","year":"1991","unstructured":"Chapman J, Alroy G, Weiss Z, Faigon M, Feldon J, Michaelson DM (1991) Anti-neuronal antibodies similar to those found in Alzheimer\u2019s disease induce memory dysfunction in rats. Neuroscience 40:297\u2013305","journal-title":"Neuroscience"},{"key":"8357_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1155\/NP.1989.63","volume":"1","author":"J Chapman","year":"1989","unstructured":"Chapman J, Feldon J, Alroy G, Michaelson DM (1989) Immunization of rats with cholinergic neurons induces behavioral deficits. J Neural Transplant 1:63\u201376","journal-title":"J Neural Transplant"},{"key":"8357_CR45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-010-8242-y","volume":"42","author":"M Benkler","year":"2012","unstructured":"Benkler M, Agmon-Levin N, Hassin-Baer S et al (2012) Immunology, autoimmunity, and autoantibodies in Parkinson\u2019s disease. Clin Rev Allergy Immunol 42:164\u2013171","journal-title":"Clin Rev Allergy Immunol"},{"key":"8357_CR46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55\u201368","journal-title":"N Engl J Med"},{"key":"8357_CR47","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","volume":"62","author":"DS Hasin","year":"2005","unstructured":"Hasin DS, Goodwin RD, Stinson FS, Grant BF (2005) Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 62:1097\u20131106","journal-title":"Arch Gen Psychiatry"},{"key":"8357_CR48","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"8357_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15622970310029904","volume":"4","author":"B Gohier","year":"2003","unstructured":"Gohier B, Goeb JL, Rannou-Dubas K, Fouchard I, Cales P, Garre JB (2003) Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry 4:115\u2013118","journal-title":"World J Biol Psychiatry"},{"key":"8357_CR50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171\u2013186","journal-title":"Psychosom Med"},{"key":"8357_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S1461145702003024","volume":"5","author":"Z Kronfol","year":"2002","unstructured":"Kronfol Z (2002) Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol 5:333\u2013343","journal-title":"Int J Neuropsychopharmacol"},{"key":"8357_CR52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0447.1989.tb01316.x","volume":"80","author":"Z Kronfol","year":"1989","unstructured":"Kronfol Z, House JD (1989) Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatr Scand 80:142\u2013147","journal-title":"Acta Psychiatr Scand"},{"key":"8357_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11\u201338","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8357_CR54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","volume":"49","author":"M Maes","year":"1993","unstructured":"Maes M, Scharpe S, Meltzer HY et al (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic\u2013pituitary\u2013adrenal axis in severe depression. Psychiatry Res 49:11\u201327","journal-title":"Psychiatry Res"},{"key":"8357_CR55","first-page":"39","volume":"25","author":"AD Valentine","year":"1998","unstructured":"Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25:39\u201347","journal-title":"Semin Oncol"},{"key":"8357_CR56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"8357_CR57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","volume":"13","author":"S Kent","year":"1992","unstructured":"Kent S, Bluthe RM, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13:24\u201328","journal-title":"Trends Pharmacol Sci"},{"key":"8357_CR58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jlb.59.4.489","volume":"59","author":"G Fantuzzi","year":"1996","unstructured":"Fantuzzi G, Dinarello CA (1996) The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 59:489\u2013493","journal-title":"J Leukoc Biol"},{"issue":"Suppl 1","key":"8357_CR59","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0889-1591(02)00065-X","volume":"17","author":"JM Krueger","year":"2003","unstructured":"Krueger JM, Majde JA, Obal F (2003) Sleep in host defense. Brain Behav Immun 17(Suppl 1):S41\u2013S47","journal-title":"Brain Behav Immun"},{"key":"8357_CR60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(97)01009-3","volume":"776","author":"AH Swiergiel","year":"1997","unstructured":"Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ (1997) The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 776:96\u2013104","journal-title":"Brain Res"},{"key":"8357_CR61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0006-3223(93)90041-B","volume":"34","author":"G Adler","year":"1993","unstructured":"Adler G, Gattaz WF (1993) Pain perception threshold in major depression. Biol Psychiatry 34:687\u2013689","journal-title":"Biol Psychiatry"},{"key":"8357_CR62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","volume":"654","author":"LR Watkins","year":"1994","unstructured":"Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654:15\u201326","journal-title":"Brain Res"},{"key":"8357_CR63","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1128\/IAI.70.9.5177-5184.2002","volume":"70","author":"X Song","year":"2002","unstructured":"Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC (2002) Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infect Immun 70:5177\u20135184","journal-title":"Infect Immun"},{"key":"8357_CR64","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1189\/jlb.0403128","volume":"75","author":"X Song","year":"2004","unstructured":"Song X, Tanaka S, Cox D, Lee SC (2004) Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras\/ERK MAPK pathways in phagocytosis and chemokine induction. J Leukoc Biol 75:1147\u20131155","journal-title":"J Leukoc Biol"},{"key":"8357_CR65","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.4049\/jimmunol.0903833","volume":"186","author":"K Lunnon","year":"2011","unstructured":"Lunnon K, Teeling JL, Tutt AL, Cragg MS, Glennie MJ, Perry VH (2011) Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J Immunol 186:7215\u20137224","journal-title":"J Immunol"},{"key":"8357_CR66","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.npp.1300371","volume":"29","author":"RS Hastings","year":"2004","unstructured":"Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ (2004) Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacol 29:952\u2013959","journal-title":"Neuropsychopharmacol"},{"key":"8357_CR67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","volume":"45","author":"HS Mayberg","year":"2005","unstructured":"Mayberg HS, Lozano AM, Voon V et al (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651\u2013660","journal-title":"Neuron"},{"key":"8357_CR68","doi-asserted-by":"crossref","first-page":"e20912","DOI":"10.1371\/journal.pone.0020912","volume":"6","author":"Y Heo","year":"2011","unstructured":"Heo Y, Zhang Y, Gao D, Miller VM, Lawrence DA (2011) Aberrant immune responses in a mouse with behavioral disorders. PLoS One 6:e20912","journal-title":"PLoS One"},{"key":"8357_CR69","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","volume":"56","author":"A Katzav","year":"2007","unstructured":"Katzav A, Solodeev I, Brodsky O et al (2007) Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 56:938\u2013948","journal-title":"Arthritis Rheum"},{"key":"8357_CR70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","volume":"38","author":"S Kivity","year":"2010","unstructured":"Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y (2010) Evidence for the use of intravenous immunoglobulins\u2014a review of the literature. Clin Rev Allergy Immunol 38:201\u2013269","journal-title":"Clin Rev Allergy Immunol"},{"key":"8357_CR71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/CRIAI:29:3:185","volume":"29","author":"T Sapir","year":"2005","unstructured":"Sapir T, Shoenfeld Y (2005) Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29:185\u2013199","journal-title":"Clin Rev Allergy Immunol"},{"key":"8357_CR72","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","volume":"11","author":"SV Kaveri","year":"2012","unstructured":"Kaveri SV (2012) Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev 11:792\u2013794","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-013-8357-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-013-8357-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-013-8357-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T10:18:49Z","timestamp":1562581129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-013-8357-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["8357"],"URL":"https:\/\/doi.org\/10.1007\/s12016-013-8357-z","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]}}}